Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized, Investigator-Blinded, Parallel-group Study to Assess the Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis.

NCT01195831 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT01195831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01195831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized, Investigator-Blinded, Parallel-group Study to Assess the Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis.
Lead sponsor
LEO Pharma
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2011
Enrollment
244 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

scalp psoriasis